why choose us

First received: September 11, 2023

Clinical Trial: Pulse Endovascular ReperFUSION for Acute Ischemic Stroke

Study Status: Completed

Recruit Status: RECRUITING

Condition: Acute Ischemic Stroke AIS

Study Type: INTERVENTIONAL


Official Title: PERFUSION AIS - Pulse Endovascular ReperFUSION for Acute Ischemic Stroke: An Early Feasibility Clinical Study

Brief Summary: Prospective, multi-center, single-arm early feasibility study enrolling a minimum of 15 subjects at up to a minimum of 3 active investigational sites in the United States.The subjects must be diagnosed with acute ischemic stroke (AIS), must be post-mechanical thrombectomy, will have had intravenous thrombolytics, and have a visible MCA, ACA or PCA occlusive clot on initial angiographic imaging.Each subject will receive the Pulse NanoMED procedure after attempted neurovascular therapy to achieve better reperfusion.

Read more